# L_2005141EN.01002401.xml

| 4.6.2005 | EN | Official Journal of the European Union | L 141/24 |
| --- | --- | --- | --- |

4.6.2005

EN

Official Journal of the European Union

L 141/24

---

COMMISSION DECISION

of 30 May 2005

amending Decisions 2004/696/EC and 2004/863/EC on the Community's financial contribution to the TSE eradication and monitoring programmes for 2005

(notified under document number C(2005) 1550)

(2005/413/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (1), and in particular Article 24(5) and (6) thereof,

Whereas:

| (1) | Commission Decision 2004/696/EC of 14 October 2004 on the list of programmes for the eradication and the monitoring of certain TSEs qualifying for a financial contribution from the Community in 2005 (2) sets out the list of such programmes, as well as the proposed rate and amount of the contribution for each programme. |
| --- | --- |

(1)

Commission Decision 2004/696/EC of 14 October 2004 on the list of programmes for the eradication and the monitoring of certain TSEs qualifying for a financial contribution from the Community in 2005 (2) sets out the list of such programmes, as well as the proposed rate and amount of the contribution for each programme.

| (2) | Commission Decision 2004/863/EC of 30 November 2004 approving the TSE eradication and monitoring programmes of certain Member States for 2005 and fixing the level of the Community’s financial contribution (3). |
| --- | --- |

(2)

Commission Decision 2004/863/EC of 30 November 2004 approving the TSE eradication and monitoring programmes of certain Member States for 2005 and fixing the level of the Community’s financial contribution (3).

| (3) | On 28 January 2005, a Community expert panel, chaired by the Community Reference laboratory for TSEs (CRL), confirmed the detection of bovine spongiform encephalopathy (BSE) in a goat slaughtered in France. It was the first case of BSE in a small ruminant under natural conditions. |
| --- | --- |

(3)

On 28 January 2005, a Community expert panel, chaired by the Community Reference laboratory for TSEs (CRL), confirmed the detection of bovine spongiform encephalopathy (BSE) in a goat slaughtered in France. It was the first case of BSE in a small ruminant under natural conditions.

| (4) | In its statement of 28 January 2005, the Scientific Panel on Biological Hazards of the European Food Safety Authority (EFSA) stressed that the significance of that single case of BSE infection in a goat in France is yet to be assessed. In order to do so, the EFSA indicated that the results of an increased monitoring of TSEs in goats are essential. |
| --- | --- |

(4)

In its statement of 28 January 2005, the Scientific Panel on Biological Hazards of the European Food Safety Authority (EFSA) stressed that the significance of that single case of BSE infection in a goat in France is yet to be assessed. In order to do so, the EFSA indicated that the results of an increased monitoring of TSEs in goats are essential.

| (5) | In response to that statement, Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (4), as amended by Commission Regulation (EC) No 214/2005 (5), introduced a new programme for the monitoring of TSE in caprine animals starting from 11 February 2005. Under that new monitoring programme, the numbers of healthy slaughter and dead-on-farm caprine animals to be tested have been substantially increased. |
| --- | --- |

(5)

In response to that statement, Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (4), as amended by Commission Regulation (EC) No 214/2005 (5), introduced a new programme for the monitoring of TSE in caprine animals starting from 11 February 2005. Under that new monitoring programme, the numbers of healthy slaughter and dead-on-farm caprine animals to be tested have been substantially increased.

| (6) | Due to the particularities of the goat meat sector, the limited value of goats above 18 months of age for slaughter purposes, and in the light of the importance of an effective implementation of the increased monitoring to assess the prevalence of BSE in caprine animals, it is appropriate to increase the amount per test to be reimbursed to the Member States by the Community up to a maximum amount of EUR 30 per rapid test performed in caprine animals. |
| --- | --- |

(6)

Due to the particularities of the goat meat sector, the limited value of goats above 18 months of age for slaughter purposes, and in the light of the importance of an effective implementation of the increased monitoring to assess the prevalence of BSE in caprine animals, it is appropriate to increase the amount per test to be reimbursed to the Member States by the Community up to a maximum amount of EUR 30 per rapid test performed in caprine animals.

| (7) | In addition, Regulation (EC) 999/2001, as amended Commission Regulation (EC) No 36/2005 (6) sets out the compulsory systematic discriminatory testing to differentiate BSE from scrapie in all TSE cases detected in ovine and caprine animals to apply from 14 January 2005. That measure should be considered as eligible for the Community’s financial contribution to the TSE monitoring and eradication programmes in the Member States. |
| --- | --- |

(7)

In addition, Regulation (EC) 999/2001, as amended Commission Regulation (EC) No 36/2005 (6) sets out the compulsory systematic discriminatory testing to differentiate BSE from scrapie in all TSE cases detected in ovine and caprine animals to apply from 14 January 2005. That measure should be considered as eligible for the Community’s financial contribution to the TSE monitoring and eradication programmes in the Member States.

| (8) | In the light of the importance to assess the prevalence of BSE in small ruminants for the achievement of Community objectives in the field of public and animal health it is appropriate to reimburse 100% of the costs paid by the Member States for the primary molecular tests to differentiate BSE from scrapie. |
| --- | --- |

(8)

In the light of the importance to assess the prevalence of BSE in small ruminants for the achievement of Community objectives in the field of public and animal health it is appropriate to reimburse 100% of the costs paid by the Member States for the primary molecular tests to differentiate BSE from scrapie.

| (9) | Therefore, it is necessary to revise the maximum amount of financial participation by the Community for each programme, as set out in Decisions 2004/696/EC and 2004/863/EC. |
| --- | --- |

(9)

Therefore, it is necessary to revise the maximum amount of financial participation by the Community for each programme, as set out in Decisions 2004/696/EC and 2004/863/EC.

| (10) | Decision 2004/863/EC sets out the conditions for the Community’s financial contribution, including the forwarding of a monthly report to the Commission by the concerned Member States on the progress of the TSE monitoring programmes and the cost paid. The Annex to that sets out the costs to be paid. That Annex should be amended to take account of amendments to Annexes III and X to Regulation (EC) No 999/2001, as amended by Regulation (EC) No 36/2005 and No 214/2005. |
| --- | --- |

(10)

Decision 2004/863/EC sets out the conditions for the Community’s financial contribution, including the forwarding of a monthly report to the Commission by the concerned Member States on the progress of the TSE monitoring programmes and the cost paid. The Annex to that sets out the costs to be paid. That Annex should be amended to take account of amendments to Annexes III and X to Regulation (EC) No 999/2001, as amended by Regulation (EC) No 36/2005 and No 214/2005.

| (11) | Decisions 2004/696/EC and 2004/863/EC should therefore be amended accordingly. |
| --- | --- |

(11)

Decisions 2004/696/EC and 2004/863/EC should therefore be amended accordingly.

| (12) | The measures provided for in this Decision are in accordance with the opinion of the Standing Committee of the Food Chain and Animal Health, |
| --- | --- |

(12)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee of the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

Annex I to Decision 2004/696/EC is amended in accordance with Annex I to this Decision.

Article 2

Decision 2004/863/EC is amended as follows:

| 1. | in Article 1(2), ‘EUR 3 550 000’ is replaced by ‘EUR 3 586 000’; |
| --- | --- |

1.

in Article 1(2), ‘EUR 3 550 000’ is replaced by ‘EUR 3 586 000’;

| 2. | in Article 2(2), ‘EUR 1 700 000’ is replaced by ‘EUR 1 736 000’; |
| --- | --- |

2.

in Article 2(2), ‘EUR 1 700 000’ is replaced by ‘EUR 1 736 000’;

| 3. | in Article 3(2), ‘EUR 2 375 000’ is replaced by ‘EUR 2 426 000’; |
| --- | --- |

3.

in Article 3(2), ‘EUR 2 375 000’ is replaced by ‘EUR 2 426 000’;

| 4. | in Article 4(2), ‘EUR 15 020 000’ is replaced by ‘EUR 15 170 000’; |
| --- | --- |

4.

in Article 4(2), ‘EUR 15 020 000’ is replaced by ‘EUR 15 170 000’;

| 5. | in Article 5(2), ‘EUR 290 000’ is replaced by ‘EUR 294 000’; |
| --- | --- |

5.

in Article 5(2), ‘EUR 290 000’ is replaced by ‘EUR 294 000’;

| 6. | in Article 6(2), ‘EUR 585 000’ is replaced by ‘EUR 1 487 000’; |
| --- | --- |

6.

in Article 6(2), ‘EUR 585 000’ is replaced by ‘EUR 1 487 000’;

| 7. | in Article 7(2), ‘EUR 4 780 000’ is replaced by ‘EUR 8 846 000’; |
| --- | --- |

7.

in Article 7(2), ‘EUR 4 780 000’ is replaced by ‘EUR 8 846 000’;

| 8. | in Article 8(2), ‘EUR 24 045 000’ is replaced by ‘EUR 29 755 000’; |
| --- | --- |

8.

in Article 8(2), ‘EUR 24 045 000’ is replaced by ‘EUR 29 755 000’;

| 9. | in Article 9(2), ‘EUR 6 170 000’ is replaced by ‘EUR 6 172 000’; |
| --- | --- |

9.

in Article 9(2), ‘EUR 6 170 000’ is replaced by ‘EUR 6 172 000’;

| 10. | in Article 10(2), ‘EUR 6 660 000’ is replaced by ‘EUR 8 677 000’; |
| --- | --- |

10.

in Article 10(2), ‘EUR 6 660 000’ is replaced by ‘EUR 8 677 000’;

| 11. | in Article 11(2), ‘EUR 85 000’ is replaced by ‘EUR 353 000’; |
| --- | --- |

11.

in Article 11(2), ‘EUR 85 000’ is replaced by ‘EUR 353 000’;

| 12. | in Article 12(2), ‘EUR 835 000’ is replaced by ‘EUR 836 000’; |
| --- | --- |

12.

in Article 12(2), ‘EUR 835 000’ is replaced by ‘EUR 836 000’;

| 13. | in Article 13(2), ‘EUR 145 000’ is replaced by ‘EUR 155 000’; |
| --- | --- |

13.

in Article 13(2), ‘EUR 145 000’ is replaced by ‘EUR 155 000’;

| 14. | in Article 14(2), ‘EUR 1 085 000’ is replaced by ‘EUR 1 184 000’; |
| --- | --- |

14.

in Article 14(2), ‘EUR 1 085 000’ is replaced by ‘EUR 1 184 000’;

| 15. | in Article 15(2), ‘EUR 35 000’ is replaced by ‘EUR 36 000’; |
| --- | --- |

15.

in Article 15(2), ‘EUR 35 000’ is replaced by ‘EUR 36 000’;

| 16. | in Article 16(2), ‘EUR 4 270 000’ is replaced by ‘EUR 4 510 000’; |
| --- | --- |

16.

in Article 16(2), ‘EUR 4 270 000’ is replaced by ‘EUR 4 510 000’;

| 17. | in Article 17(2), ‘EUR 1 920 000’ is replaced by ‘EUR 2 076 000’; |
| --- | --- |

17.

in Article 17(2), ‘EUR 1 920 000’ is replaced by ‘EUR 2 076 000’;

| 18. | in Article 18(2), ‘EUR 1 135 000’ is replaced by ‘EUR 1 480 000’; |
| --- | --- |

18.

in Article 18(2), ‘EUR 1 135 000’ is replaced by ‘EUR 1 480 000’;

| 19. | in Article 19(2), ‘EUR 435 000’ is replaced by ‘EUR 444 000’; |
| --- | --- |

19.

in Article 19(2), ‘EUR 435 000’ is replaced by ‘EUR 444 000’;

| 20. | in Article 20(2), ‘EUR 1 160 000’ is replaced by ‘EUR 1 170 000’; |
| --- | --- |

20.

in Article 20(2), ‘EUR 1 160 000’ is replaced by ‘EUR 1 170 000’;

| 21. | in Article 21(2), ‘EUR 305 000’ is replaced by ‘EUR 313 000’; |
| --- | --- |

21.

in Article 21(2), ‘EUR 305 000’ is replaced by ‘EUR 313 000’;

| 22. | in Article 22(2), ‘EUR 5 570 000’ is replaced by ‘EUR 5 690 000’; |
| --- | --- |

22.

in Article 22(2), ‘EUR 5 570 000’ is replaced by ‘EUR 5 690 000’;

| 23. | Article 23 is replaced by the following:

  ‘Article 23
  The Community's financial contribution for the TSE monitoring programmes referred to in Articles 1 to 22 shall be at the rate of 100 % of the cost paid, value added tax excluded, by the concerned Member States for the tests performed, subject to:






  (a) | a maximum amount of EUR 8 per test, for tests carried out from 1 January to 31 December 2005 in bovine and ovine animals referred to in Annex III to Regulation (EC) No 999/2001; |
| --- | --- | --- |

23.

Article 23 is replaced by the following:

‘Article 23

The Community's financial contribution for the TSE monitoring programmes referred to in Articles 1 to 22 shall be at the rate of 100 % of the cost paid, value added tax excluded, by the concerned Member States for the tests performed, subject to:

(a)

a maximum amount of EUR 8 per test, for tests carried out from 1 January to 31 December 2005 in bovine and ovine animals referred to in Annex III to Regulation (EC) No 999/2001;

| (b) | a maximum amount of EUR 30 per test, for tests carried out from 1 January to 31 December 2005 in caprine animals referred to in Annex III to Regulation (EC) No 999/2001; |
| --- | --- |

(b)

a maximum amount of EUR 30 per test, for tests carried out from 1 January to 31 December 2005 in caprine animals referred to in Annex III to Regulation (EC) No 999/2001;

| (c) | a maximum amount of EUR 145 per test, for primary molecular discriminatory tests carried out from 14 January 2005 to 31 December 2005 as referred to in Annex X, Chapter C, point 3.2(c)(i) to Regulation (EC) No 999/2001.’; |
| --- | --- |

(c)

a maximum amount of EUR 145 per test, for primary molecular discriminatory tests carried out from 14 January 2005 to 31 December 2005 as referred to in Annex X, Chapter C, point 3.2(c)(i) to Regulation (EC) No 999/2001.’;

| 24. | the Annex is replaced by Annex II to this Decision. |
| --- | --- |

24.

the Annex is replaced by Annex II to this Decision.

Article 3

This Decision is addressed to the Member States.

Done at Brussels, 30 May 2005.

For the Commission

Markos KYPRIANOU

Member of the Commission

---

(1)  
  OJ L 224, 18.8.1990, p. 19. Decision as last amended by Regulation (EC) No 806/2003 (OJ L 122, 16.5.2003, p. 1).

1

(2)  
  OJ L 316, 15.10.2004, p. 91.

2

(3)  
  OJ L 370, 17.12.2004, p. 82.

3

(4)  
  OJ L 147, 31.5.2001, p. 1. Regulation as last amended by Commission Regulation (EC) 260/2005 (OJ L 46, 17.2.2005, p. 9).

4

(5)  
  OJ L 37, 10.2.2005, p. 9.

5

(6)  
  OJ L 10, 13.1.2005, p. 9.

6

---

ANNEX I

Annex I to Decision 2004/696/EC is replaced by the following:

‘ANNEX I

List of programmes for the monitoring of TSEs

Rate and maximum amount of the Community financial contribution

| (in EUR) |
| --- |
| Disease | Member State | Rate tests (1) performed | Maximum amount |
| TSEs | Austria | 100  % | 2 076 000 |
| Belgium | 100  % | 3 586 000 |
| Cyprus | 100  % | 353 000 |
| Czech Republic | 100  % | 1 736 000 |
| Denmark | 100  % | 2 426 000 |
| Estonia | 100  % | 294 000 |
| Finland | 100  % | 1 170 000 |
| France | 100  % | 29 755 000 |
| Germany | 100  % | 15 170 000 |
| Greece | 100  % | 1 487 000 |
| Hungary | 100  % | 1 184 000 |
| Ireland | 100  % | 6 172 000 |
| Italy | 100  % | 8 677 000 |
| Lithuania | 100  % | 836 000 |
| Luxembourg | 100  % | 155 000 |
| Malta | 100  % | 36 000 |
| Netherlands | 100  % | 4 510 000 |
| Portugal | 100  % | 1 480 000 |
| Slovenia | 100  % | 444 000 |
| Spain | 100  % | 8 846 000 |
| Sweden | 100  % | 313 000 |
| United Kingdom | 100  % | 5 690 000 |
| Total | 96 396 000 |

(in EUR)

Disease

Member State

Rate tests (1) performed

Maximum amount

TSEs

Austria

100  %

2 076 000

Belgium

100  %

3 586 000

Cyprus

100  %

353 000

Czech Republic

100  %

1 736 000

Denmark

100  %

2 426 000

Estonia

100  %

294 000

Finland

100  %

1 170 000

France

100  %

29 755 000

Germany

100  %

15 170 000

Greece

100  %

1 487 000

Hungary

100  %

1 184 000

Ireland

100  %

6 172 000

Italy

100  %

8 677 000

Lithuania

100  %

836 000

Luxembourg

100  %

155 000

Malta

100  %

36 000

Netherlands

100  %

4 510 000

Portugal

100  %

1 480 000

Slovenia

100  %

444 000

Spain

100  %

8 846 000

Sweden

100  %

313 000

United Kingdom

100  %

5 690 000

Total

96 396 000

---

(1)  Rapid tests and primary molecular tests.’

1

---

ANNEX II

‘ANNEX

| TSE monitoring |
| --- |
| Member State: | Month: | Year: |

TSE monitoring

Member State:

Month:

Year:

| Tests on bovine animals |
| --- |
| | Number of tests | Unit cost | Total cost |
| Tests on animals referred to in Annex III, Chapter A, Part I, points 2.1, 3 and 4.1 to Regulation (EC) No 999/2001 | | | |
| Tests on animals referred to in Annex III, Chapter A, Part I, points 2.2, 4.2 and 4.3 to Regulation (EC) No 999/2001 | | | |
| Total | | | |

Tests on bovine animals

Number of tests

Unit cost

Total cost

Tests on animals referred to in Annex III, Chapter A, Part I, points 2.1, 3 and 4.1 to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part I, points 2.2, 4.2 and 4.3 to Regulation (EC) No 999/2001

Total

| Tests on ovine animals |
| --- |
| | Number of tests | Unit cost | Total cost |
| Tests on animals referred to in Annex III, Chapter A, Part II, point 2(a) to Regulation (EC) No 999/2001 | | | |
| Tests on animals referred to in Annex III, Chapter A, Part II, point 3 to Regulation (EC) No 999/2001 | | | |
| Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001 | | | |
| Total | | | |

Tests on ovine animals

Number of tests

Unit cost

Total cost

Tests on animals referred to in Annex III, Chapter A, Part II, point 2(a) to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part II, point 3 to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001

Total

| Tests on caprine animals |
| --- |
| | Number of tests | Unit cost | Total cost |
| Tests on animals referred to in Annex III, Chapter A, Part II, point 2(b) to Regulation (EC) No 999/2001 | | | |
| Tests on animals referred to in Annex III, Chapter A, Part II, point 3 to Regulation (EC) No 999/2001 | | | |
| Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001 | | | |
| Total | | | |

Tests on caprine animals

Number of tests

Unit cost

Total cost

Tests on animals referred to in Annex III, Chapter A, Part II, point 2(b) to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part II, point 3 to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001

Total

| Primary molecular testing with a discriminatory immuno-blotting |
| --- |
| | Number of tests | Unit cost | Total cost |
| Tests on animals referred to in Annex X, Chapter C, point 3.2 (c) (i) to Regulation (EC) No 999/2001’ | | | |

Primary molecular testing with a discriminatory immuno-blotting

Number of tests

Unit cost

Total cost

Tests on animals referred to in Annex X, Chapter C, point 3.2 (c) (i) to Regulation (EC) No 999/2001’

---